A randomised controlled trial of effectiveness and safety of Niclosamide as add on therapy to the standard of care measures in COVID-19 management

BACKGROUND: COVID-19 pandemic has ignited the urge for repurposing old drugs as candidate antiviral medicines to treat novel challenges of viral infections. Niclosamide (NCS) is an anti-parasitic drug of known antiviral potential. Therefore, this study attempts to investigate the antiviral effect an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulamir, Ahmed S., Gorial, Faiq I., Saadi, Sattar Jabar, Maulood, Mohammed Fauzi, Hashim, Hashim Ali, Alnuaimi, Ahmed Sameer, abdulrrazaq, Manal K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Health Economic Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416702/
https://www.ncbi.nlm.nih.gov/pubmed/34512959
http://dx.doi.org/10.1016/j.amsu.2021.102779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416702/
https://www.ncbi.nlm.nih.gov/pubmed/34512959
http://dx.doi.org/10.1016/j.amsu.2021.102779

Ejemplares similares